Biotech companies in China are looking forand products, preferably with POC data already.
If you are interested in these licensing opportunities, please contact DrugTimes at BD@drugtimes.cn.
Please kindly share non-confidential materials ONLY.
Thank you very much for your understanding and support!
Look forward to win-win collaborations in 2020 and beyond!